Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Core EBITDA Growth

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Core EBITDA Growth(%) 25.857.7265.570.03-4.21

What is the latest Core EBITDA Growth ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Core EBITDA Growth ratio of SYNCOM FORMULATIONS (INDIA) is 25.85 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202425.85
Mar20237.72
Mar202265.57
Mar20170.03
Mar2016-4.21

How is Core EBITDA Growth of SYNCOM FORMULATIONS (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 25.85
234.84
Mar2023 7.72
-88.23
Mar2022 65.57
218,466.67
Mar2017 0.03
Positive
Mar2016 -4.21 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Core EBITDA Growth ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,802.0 Cr -10% -2.7% 48.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,249.0 Cr -1.3% -3.3% 8.3% Stock Analytics
DIVIS LABORATORIES ₹174,940.0 Cr -1.5% 0.8% 42.3% Stock Analytics
CIPLA ₹121,197.0 Cr -1.7% 2.3% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,618.0 Cr -1.6% 8.4% 10.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,250.0 Cr -3.3% -1.4% 9.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-10%

-2.7%

48.3%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses